Most recently, Liu et al. [64] showed a similar correlation between histologic features of inflammation and synovial thickening on MRI. These studies demonstrate the ability of current imaging techniques to non-invasively detect synovial inflammation, and provide further evidence that synovitis is an important contributor to OA pathobiology. The above sections describe two approaches, histology and imaging, utilized to identify synovitis in patients with OA. These approaches, as well as direct arthroscopic visualization, have documented anatomic variability in the location of the synovitis in the knee joint, which is most commonly

studied. Early studies suggested that inflammation is more focal in OA than the widespread synovitis seen in RA, with synovium abutting cartilage learn more lesions [36] or perimeniscal areas [3] preferentially involved. A relationship between symptoms and synovitis localized to the infrapatellar and suprapatellar areas has been demonstrated [43]. In a recent study specifically addressing anatomic variation, Doxorubicin supplier synovitis detected by MRI was most commonly observed posterior to the posterior cruciate ligament (PCL) and in the suprapatellar region [85]. Our own studies have focused on synovitis defined histologically in patients without radiographic

evidence of OA undergoing surgery for meniscal tears [87]. Although radiographically normal, the majority of these patients have cartilage abnormalities noted intraoperatively consistent with

eltoprazine early stage OA. We examined the prevalence of synovial inflammation in these patients in three locations within the knee: suprapatellar pouch, medial gutter and lateral gutters. Of these locations, synovitis was most commonly detected in the suprapatellar pouch. There does not appear to be a single preferential location in which synovitis develops in the setting of all knee injuries and osteoarthritis, and the reasons for anatomic variation are unclear. Potential contributory factors include (i) biomechanical forces, (ii) local cartilage or other soft tissue injuries at specific locations, and (iii) differences in cellular or matrix composition at these anatomic sites that may be more conducive to the development of synovial inflammation. Many decades of research have demonstrated the clinical significance of synovitis in the setting of RA. These studies led to the development of therapies (i.e. the anti-TNF agents) that improved the clinical course and outcomes for patients with RA. It is only in the past decade, though, that research efforts have been directed at understanding how the low-grade synovitis of OA relates to disease manifestations.